There were lots of things that stuck out. One in breast cancer, the arrival of a new drug that basically reduces the risk of breast cancer coming back by a quarter. And then one in ovarian cancer where they're looking at combinations of drugs. I think there's a long way to go before we'd see this kind of early detection blood cancer test used in a large population.
Ian Sample speaks to the Guardian’s health editor, Andrew Gregory, and Dr Roy Herbst about the world’s biggest annual gathering of oncology professionals. Each year’s event features a mass of new research, and 2023 was no exception. What were the standout advances, and could they lead to permanent changes in the way we treat, think about and live with cancer?. Help support our independent journalism at
theguardian.com/sciencepod